American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond

USA News Group News Commentary – According to the American Cancer Society, 2024 will be the first year the USA expects to have more than 2 million...

PR NewswireJun 27 15:28 ET

Oncolytics Biotech Advances Breast Cancer Trial With FDA Support

Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, today announced that the Company received productive feedback from it

BenzingaJun 27 07:05 ET

Oncolytics Biotech Brief: Announcing Productive FDA Type C Meeting on Its Metastatic Breast Cancer Program

07:00 AM EDT, 06/27/2024 (MT Newswires) -- Oncolytics Biotech Brief: Announcing Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

MT NewswiresJun 27 07:00 ET

Oncolytics Biotech Chair Wayne Pisano To Serve As Interim CEO As Dr. Matt Coffey Looks To Take Medical Leave Of Absence

Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, today announced that Matt Coffey, PhD, President and Chief Executive

BenzingaJun 24 07:08 ET

Maxim Group Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Maintains Target Price $5

Maxim Group analyst Jason McCarthy maintains $Oncolytics Biotech(ONCY.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 24.0% a

Moomoo NewsJun 21 12:31 ET · Ratings

Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike

USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer...

PR NewswireJun 20 17:26 ET